Unraveling the complexities of caffeine: metabolism, genetics, evolution, and health.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanisms, genetics, and epidemiology without primary data or systematic meta-analysis
PubMed 41622288 · doi:10.1186/s41065-026-00648-z
What was done
The authors conducted a narrative synthesis of literature across pharmacogenomics, evolutionary genetics, and epidemiology regarding caffeine metabolism. The review examined the hepatic enzyme CYP1A2 and transcriptional regulator AHR, genetic polymorphisms and GWAS signals, ancient DNA evidence for evolutionary pressures, non-genetic modulators (such as smoking, pregnancy, diet, and medications), and interactions with cardiovascular, neurological, and metabolic health outcomes.
What was found
The abstract reports no numerical data or quantitative effect sizes. It describes qualitative findings: genetic variation in CYP1A2 and AHR delineates slow from rapid caffeine metabolizers, evolutionary history has shaped population-level tolerance patterns, and non-genetic exposures dynamically alter metabolic rates and subsequent health outcomes.
Why it matters
This review integrates pharmacogenetics with evolutionary biology to emphasize that health effects of caffeine vary widely between individuals, supporting the need for personalized intake guidelines rather than universal population recommendations.
Limits
As a narrative review, the paper presents no original data, systematic search methodology, or quantitative pooling. The abstract lacks specific statistical metrics, sample sizes, and detailed inclusion criteria, limiting independent assessment of the underlying evidence base.
Cited by
- supports Approximately 90 percent of the adult world consumes caffeine.